360 related articles for article (PubMed ID: 23869765)
1. Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.
Luo X; Dong Z; Chen Y; Yang L; Lai D
Cell Prolif; 2013 Aug; 46(4):436-46. PubMed ID: 23869765
[TBL] [Abstract][Full Text] [Related]
2. LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer.
Chao TK; Yo YT; Liao YP; Wang YC; Su PH; Huang TS; Lai HC
Gynecol Oncol; 2013 Mar; 128(3):475-82. PubMed ID: 23270808
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
[TBL] [Abstract][Full Text] [Related]
5. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.
Han M; Liu M; Wang Y; Chen X; Xu J; Sun Y; Zhao L; Qu H; Fan Y; Wu C
PLoS One; 2012; 7(6):e39520. PubMed ID: 22761812
[TBL] [Abstract][Full Text] [Related]
7. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
8. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor.
Liu KC; Yo YT; Huang RL; Wang YC; Liao YP; Huang TS; Chao TK; Lin CK; Weng SJ; Ma KH; Chang CC; Yu MH; Lai HC
Oncotarget; 2013 Dec; 4(12):2366-82. PubMed ID: 24280306
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
11. IQGAP1 Is Involved in Enhanced Aggressive Behavior of Epithelial Ovarian Cancer Stem Cell-Like Cells During Differentiation.
Huang L; Xu S; Hu D; Lu W; Xie X; Cheng X
Int J Gynecol Cancer; 2015 May; 25(4):559-65. PubMed ID: 25675045
[TBL] [Abstract][Full Text] [Related]
12. TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas.
Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Akiya M; Saegusa M
Mol Carcinog; 2018 Aug; 57(8):957-967. PubMed ID: 29603383
[TBL] [Abstract][Full Text] [Related]
13. CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.
Long H; Xiang T; Qi W; Huang J; Chen J; He L; Liang Z; Guo B; Li Y; Xie R; Zhu B
Oncotarget; 2015 Mar; 6(8):5846-59. PubMed ID: 25788271
[TBL] [Abstract][Full Text] [Related]
14. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.
Yang CF; Yang GD; Huang TJ; Li R; Chu QQ; Xu L; Wang MS; Cai MD; Zhong L; Wei HJ; Huang HB; Huang JL; Qian CN; Huang BJ
Oncogene; 2016 Jun; 35(26):3419-31. PubMed ID: 26568302
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
Cell Death Dis; 2013 Oct; 4(10):e875. PubMed ID: 24157869
[TBL] [Abstract][Full Text] [Related]
16. CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovarian carcinomas.
Yu H; Zhang L; Liu P
Tumour Biol; 2015 Mar; 36(3):1679-83. PubMed ID: 25359618
[TBL] [Abstract][Full Text] [Related]
17. miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation.
Wuerkenbieke D; Wang J; Li Y; Ma C
Arch Gynecol Obstet; 2015 Nov; 292(5):1109-16. PubMed ID: 25986891
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
Jiang HW; Li L; Jiang P; Wang YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
[TBL] [Abstract][Full Text] [Related]
20. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Dai C; Xie Y; Zhuang X; Yuan Z
Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
